Designing herpes viruses as oncolytics per Cole Peters, Samuel D Rabkin

Obtenir text complet

Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells per Kimia Kardani, Judit Sanchez Gil, Samuel D. Rabkin

Obtenir text complet

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma per Dipongkor Saha, Samuel D Rabkin, Robert L Martuza

Obtenir text complet

Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade per Praveen K. Bommareddy, Samuel D. Rabkin, Howard L. Kaufman

Obtenir text complet

Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma per Ali Chahlavi, Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin

Obtenir text complet

In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV per Nusrat Jahan, Shanawaz M. Ghouse, Robert L. Martuza, Samuel D. Rabkin

Obtenir text complet

Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma per Praveen K. Bommareddy, Andrew Zloza, Samuel D. Rabkin, Howard L. Kaufman

Obtenir text complet

Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival per Howard L Kaufman, Dipongkor Saha, Samuel D Rabkin, Robert L Martuza, Praveen K Bommareddy, Hiroaki Wakimoto

Obtenir text complet

Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy? per Howard L Kaufman, Hongbin Wang, Dipongkor Saha, Samuel D Rabkin, Mia Borlongan, Uyen Le, Hans J Nauwynck

Obtenir text complet

Ionizing Radiation Does Not Alter the Antitumor Activity of Herpes Simplex Virus Vector G207 in Subcutaneous Tumor Models of Human and Murine Prostate Cancer per Timothy J. Jorgensen, Sanford Katz, Ellen K. Wittmack, Susan Varghese, Tomoki Todo, Samuel D. Rabkin, Robert L. Martuza

Obtenir text complet

Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells per Lei Wang, Jianfang Ning, Hiroaki Wakimoto, Shulin Wu, Chin-lee Wu, Melissa R. Humphrey, Samuel D. Rabkin, Robert L. Martuza

Obtenir text complet

Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models per Wei Zhang, Giulia Fulci, Hiroaki Wakimoto, Tooba A. Cheema, Jason S. Buhrman, Deva S. Jeyaretna, Anat O. Stemmer Rachamimov, Samuel D. Rabkin, Robert L. Martuza

Obtenir text complet

Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma per Jian-Fang Ning, Monica Stanciu, Melissa R. Humphrey, Joshua Gorham, Hiroko Wakimoto, Reiko Nishihara, Jacqueline Lees, Lee Zou, Robert L. Martuza, Hiroaki Wakimoto, Samuel D. Rabkin

Obtenir text complet

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma per Ming Li, Guoping Li, Juri Kiyokawa, Zain Tirmizi, Leland G. Richardson, Jianfang Ning, Saumya Das, Robert L. Martuza, Anat Stemmer-Rachamimov, Samuel D. Rabkin, Hiroaki Wakimoto

Obtenir text complet

An Aberrant Transcription Factor Network Essential for Wnt Signaling and Stem Cell Maintenance in Glioblastoma per Esther Rheinbay, Mario L. Suvà, Shawn M. Gillespie, Hiroaki Wakimoto, Anoop P. Patel, Mohammad Shahid, Ozgur Oksuz, Samuel D. Rabkin, Robert L. Martuza, Miguel N. Rivera, David N. Louis, Simon Kasif, Andrew S. Chi, Bradley E. Bernstein

Obtenir text complet

A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS) per Ming-Ru Wu, Lior Nissim, Doron Stupp, Erez Pery, Adina Binder-Nissim, Karen Weisinger, Casper Enghuus, Sebastian R. Palacios, Melissa Humphrey, Zhizhuo Zhang, Eva Maria Novoa, Manolis Kellis, Ron Weiss, Samuel D. Rabkin, Yuval Tabach, Timothy K. Lu

Obtenir text complet